REPLIGEN CORP
Bioprocessing equipment and consumables for biologic drug manufacturing
- Sector
- Biotech
- Headquarters
- WALTHAM, MA
- Latest Form D
- $48M, Jun 2019
- Total capital
- $306M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $291M
- 3 Form D · last Jun 2019
- 88 months since last filing
- Federal contracts
- $14.9M
- 14 awards · Health and Human S, Veterans Affairs, Defense
- Rank in Biotech#48 of 4373
- Granted patents
- 1
- first 2026
- Rank in peer group#11 of 32
Capital timeline
Latest events
- Federal contractHealth and Human S · Xcell Lab Controllers And Accessories$175K
- Federal contractHealth and Human S · KR2I Base System Tangential Flow Filtration (tff)$34K
- Federal contractDefense · Equipment KR2I Tff System - Kf Comm 2 For The Walter Reed Army Instittue Of Research (wrair)$49K
- Federal contractHealth and Human S · Tff System$30K
- Federal contractHealth and Human S · Pharmaceutical Consumables Expansion And Acceleration: Single Use Bags, Assemblies, And Tubing$14.4M
- Federal contractHealth and Human S · Opioids - Automated Tangential Flow Filtration System (atff)$24K
- Federal contractDefense · Sv-maint-lyr (yearly Maint)$4K
- Private capital raisedForm D · SEC · 3rd filing$48M
- Private capital raisedForm D · SEC · 2nd filing$239M
- Private capital raisedForm D · SEC · 1st filing$4M
Show 7 earlier federal awards
- Federal contractDefense · Kmpi System$43K
- Federal contractHealth and Human S · Robocolumn Order$20K
- Federal contractDefense · KR2I Tff System Pn: SYR2-U20, Arlyn Scale 9X8 20KG Pn: ACSC-20K-0908.$27K
- Federal contractVeterans Affairs · KR2I Filtration System And Corresponding Components$42K
- Federal contractHealth and Human S · Igf::cl::igf Atf Parts And Consumables$21K
- Federal contractHealth and Human S · Bioreactor Parts&repligen Atf Devices$104K
- Federal contractHealth and Human S · Repligen Corporation [11-013627] Can 8383165$5K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
34months
from REPLIGEN CORP’s first federal award to its first private round.
- First federal award · Aug 2011
- Health and Human S · $5K
- First Form D · Jun 2014
- $4M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 32 peers
Line = medianBiotech · Device
- Granted patents#11 · top 34%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- ALFRED L. GOLDBERGDirectorNamed in SEC Form D filings
- ANTHONY C. HUNTExecutive OfficerNamed in SEC Form D filings
- DANIEL P. WITTExecutive OfficerNamed in SEC Form D filings
- Glenn L. CooperDirectorNamed in SEC Form D filings
- Glenn P. MuirDirectorNamed in SEC Form D filings
- Howard K. BenjaminExecutive OfficerNamed in SEC Form D filings
Show all 17 people
- JAMES R. RUSCHEExecutive OfficerNamed in SEC Form D filings
- John G. CoxDirectorNamed in SEC Form D filings
- Jon K. SnodgresExecutive OfficerNamed in SEC Form D filings
- KAREN A. DAWESDirectorNamed in SEC Form D filings
- MICHAEL A. GRIFFITHDirectorNamed in SEC Form D filings
- NICOLAS F. BARTHELEMYDirectorNamed in SEC Form D filings
- Ralf J. KuriyelExecutive OfficerNamed in SEC Form D filings
- THOMAS F. RYAN , JR.DirectorNamed in SEC Form D filings
- Thomas F. Ryan, Jr.DirectorNamed in SEC Form D filings
- Tony J. HuntExecutive Officer, DirectorNamed in SEC Form D filings
- WALTER C. HERLIHYExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 1- New patentVessel, System, And Associated Method For Product ConcentrationUSPTOUS 12,746,513
Related companies, and why
- PTC TherapeuticsSimilar federal contract value in Biotech · $18.6M in contracts
- TALPHERA, INC.Similar federal contract value in Biotech · $17M in contracts
- BIOPROTECTION SYSTEMS CORPORATIONSimilar federal contract value in Biotech · $15.9M in contracts
- AUTOIMMUNE TECHNOLOGIES, LLCSimilar federal contract value in Biotech · $14.8M in contracts
- BLUEWILLOW BIOLOGICS INCSimilar federal contract value in Biotech · $14.7M in contracts
- VitriVaxSimilar federal contract value in Biotech · $14.5M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .